204 related articles for article (PubMed ID: 20535779)
1. Application of LC-NMR to the identification of bulk drug impurities in NK1 antagonist GW597599 (vestipitant).
Provera S; Guercio G; Turco L; Curcuruto O; Alvaro G; Rossi T; Marchioro C
Magn Reson Chem; 2010 Jul; 48(7):523-30. PubMed ID: 20535779
[TBL] [Abstract][Full Text] [Related]
2. Application of LC-NMR and HR-NMR to the characterization of biphenyl impurities in the synthetic route development for vestipitant, a novel NK1 antagonist.
Provera S; Martini L; Guercio G; Turco L; Costa L; Marchioro C
J Pharm Biomed Anal; 2010 Nov; 53(3):389-95. PubMed ID: 20478677
[TBL] [Abstract][Full Text] [Related]
3. Structural studies of racecadotril and its process impurities by NMR and mass spectroscopy.
Reddy KM; Babu JM; Sudhakar P; Sharma MS; Reddy GS; Vyas K
Pharmazie; 2006 Dec; 61(12):994-8. PubMed ID: 17283655
[TBL] [Abstract][Full Text] [Related]
4. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K
J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198
[TBL] [Abstract][Full Text] [Related]
5. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
[TBL] [Abstract][Full Text] [Related]
7. LC-NMR and LC-MS identification of an impurity in a novel antifungal drug icofungipen.
Novak P; Tepes P; Ilijas M; Fistrić I; Bratos I; Avdagić A; Hamersak Z; Marković VG; Dumić M
J Pharm Biomed Anal; 2009 Aug; 50(1):68-72. PubMed ID: 19410412
[TBL] [Abstract][Full Text] [Related]
8. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
[TBL] [Abstract][Full Text] [Related]
9. Preparative isolation and structural elucidation of impurities in fluconazole by LC/MS/MS.
Dongre VG; Karmuse PP; Ghugre PD; Salunke SM; Panda N; Kumar A
J Pharm Biomed Anal; 2006 Sep; 42(3):334-40. PubMed ID: 16757140
[TBL] [Abstract][Full Text] [Related]
10. Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS.
Duarte IF; Legido-Quigley C; Parker DA; Swann JR; Spraul M; Braumann U; Gil AM; Holmes E; Nicholson JK; Murphy GM; Vilca-Melendez H; Heaton N; Lindon JC
Mol Biosyst; 2009 Feb; 5(2):180-90. PubMed ID: 19156264
[TBL] [Abstract][Full Text] [Related]
11. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
12. Semi-preparative LC-SPE-cryoflow NMR for impurity identifications: use of mother liquor as a better source of impurities.
Rinaldi F; Fan J; Pathirana C; Palaniswamy V
Magn Reson Chem; 2013 Sep; 51(9):517-22. PubMed ID: 23788325
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization of impurities in pioglitazone.
Kumar YR; Reddy AR; Eswaraiah S; Mukkanti K; Reddy MS; Suryanarayana MV
Pharmazie; 2004 Nov; 59(11):836-9. PubMed ID: 15587582
[TBL] [Abstract][Full Text] [Related]
14. Identification of impurities in ivermectin bulk material by mass spectrometry and NMR.
Beasley CA; Hwang TL; Fliszar K; Abend A; McCollum DG; Reed RA
J Pharm Biomed Anal; 2006 Jun; 41(4):1124-34. PubMed ID: 16554137
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of potential impurities of donepezil.
Krishna Reddy KV; Moses Babu J; Kumar PA; Chandrashekar ER; Mathad VT; Eswaraiah S; Reddy MS; Vyas K
J Pharm Biomed Anal; 2004 Sep; 35(5):1047-58. PubMed ID: 15336352
[TBL] [Abstract][Full Text] [Related]
16. LC-UV-solid-phase extraction-NMR-MS combined with a cryogenic flow probe and its application to the identification of compounds present in Greek oregano.
Exarchou V; Godejohann M; van Beek TA; Gerothanassis IP; Vervoort J
Anal Chem; 2003 Nov; 75(22):6288-94. PubMed ID: 14616013
[TBL] [Abstract][Full Text] [Related]
17. The application of LC-NMR and LC-MS for the separation and rapid structure elucidation of an unknown impurity in 5-aminosalicylic acid.
Novak P; Tepes P; Fistrić I; Bratos I; Gabelica V
J Pharm Biomed Anal; 2006 Mar; 40(5):1268-72. PubMed ID: 16253464
[TBL] [Abstract][Full Text] [Related]
18. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
[TBL] [Abstract][Full Text] [Related]
19. Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry.
Vuletić M; Cindrić M; Koruznjak JD
J Pharm Biomed Anal; 2005 Apr; 37(4):715-21. PubMed ID: 15797793
[TBL] [Abstract][Full Text] [Related]
20. Application of high-performance liquid chromatography hyphenated techniques for identification of degradation products of cefpodoxime proxetil.
Fukutsu N; Kawasaki T; Saito K; Nakazawa H
J Chromatogr A; 2006 Oct; 1129(2):153-9. PubMed ID: 16846608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
